Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Miravitlles

Showing results (31-40 of 563) with videos related to

Pageof 57
Sort By:
Archivos De Bronconeumologia|May 9, 2021
GesEPOC 2021 and GOLD 2021. Closer Together or Further Apart?Marc Miravitlles
BMC Pulmonary Medicine|March 24, 2021
Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesisIgor Barjaktarevic, Marc Miravitlles
Therapeutic Advances in Respiratory Disease|July 21, 2009
Efficacy of tiotropium in the prevention of exacerbations of COPDAntonio Anzueto, Marc Miravitlles
The European Respiratory Journal|May 2, 2015
Are C-reactive protein levels associated with bacteria in COPD exacerbations?Marc Miravitlles, Carl Llor
Medicina Clinica|February 2, 2017
Prescription of physical activity in chronic obstructive pulmonary disease… and beyondEulogio Pleguezuelos, Marc Miravitlles
Respirology (Carlton, Vic.)|June 2, 2007
It's time for an aetiology-based definition of chronic obstructive pulmonary diseaseMarc Miravitlles, Josep Morera
Archivos De Bronconeumologia|November 3, 2019
Pulmonary Rehabilitation… Yes But NoEulogio Pleguezuelos, Marc Miravitlles
Respiratory Medicine|December 11, 2012
Chronic bronchial infection in COPD. Is there an infective phenotype?Zinka Matkovic, Marc Miravitlles
The European Respiratory Journal|November 23, 2019
Treatment with inhaled α1-antitrypsin: a square peg in a round hole?Miriam Barrecheguren, Marc Miravitlles
Multidisciplinary Respiratory Medicine|March 19, 2016
COPD heterogeneity: implications for managementMiriam Barrecheguren, Marc Miravitlles
Pageof 57

Showing results (31-40 of 563) with videos related to

Sort By:
Pageof 57
Archivos De Bronconeumologia|May 9, 2021
GesEPOC 2021 and GOLD 2021. Closer Together or Further Apart?Marc Miravitlles
BMC Pulmonary Medicine|March 24, 2021
Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesisIgor Barjaktarevic, Marc Miravitlles
Therapeutic Advances in Respiratory Disease|July 21, 2009
Efficacy of tiotropium in the prevention of exacerbations of COPDAntonio Anzueto, Marc Miravitlles
The European Respiratory Journal|May 2, 2015
Are C-reactive protein levels associated with bacteria in COPD exacerbations?Marc Miravitlles, Carl Llor
Medicina Clinica|February 2, 2017
Prescription of physical activity in chronic obstructive pulmonary disease… and beyondEulogio Pleguezuelos, Marc Miravitlles
Respirology (Carlton, Vic.)|June 2, 2007
It's time for an aetiology-based definition of chronic obstructive pulmonary diseaseMarc Miravitlles, Josep Morera
Archivos De Bronconeumologia|November 3, 2019
Pulmonary Rehabilitation… Yes But NoEulogio Pleguezuelos, Marc Miravitlles
Respiratory Medicine|December 11, 2012
Chronic bronchial infection in COPD. Is there an infective phenotype?Zinka Matkovic, Marc Miravitlles
The European Respiratory Journal|November 23, 2019
Treatment with inhaled α1-antitrypsin: a square peg in a round hole?Miriam Barrecheguren, Marc Miravitlles
Multidisciplinary Respiratory Medicine|March 19, 2016
COPD heterogeneity: implications for managementMiriam Barrecheguren, Marc Miravitlles
Pageof 57